About 5,318 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  1,356 results

Tobacco use patterns and clinical outcomes in the T1D exchange.
Journal of Diabetes and Its Complications; Rash CJ, Alessi SM et. al.

Jan 22nd, 2022 - This study examined associations between tobacco use and diabetes outcomes using the T1D Exchange Registry. Adult participants (N = 933) completed standardized questionnaires including self-reported outcomes: past year serious hypoglycemic and dia...

Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic K...
Diabetes Care; Kilpatrick ES, Butler AE et. al.

Jan 21st, 2022 - The measurement of blood ketones in preference to urine ketones has become a well-established tool in the diagnosis and management of diabetic ketoacidosis (DKA). However, there remains considerable disparity between diabetes guidelines regarding ...

Biomarker profiling of postmortem blood for diabetes mellitus and discussion of possibl...
https://doi.org/10.1007/s00414-021-02767-w 10.1038/nrendo.2011.183 10.3325/cmj.2015.56.181 10.1007/s00414-011-0625-y 10.1520/JFS15578J 10.5858/1999-123-0763-EOAFAH 10.2337/dc13-0610 10.1371/journal.pone.0040459 10.1021/ac101421b 10.1038/srep07796 10.1194/jlr.M400008-JLR200 10.1002/rcm.3947 10.1021/acs.jproteome.8b00169 10.1371/journal.pone.0105181 10.1007/s00414-017-1657-8 10.15761/IMM.1000278 10.1139/o59-099 10.1002/cpbi.11 10.1038/nmeth.339310.1038/nmeth.3393 10.1021/acs.analchem.6b00770 10.1007/BF02088748 10.1016/S0009-3084(99)00079-1 10.1038/nature13475 10.1161/ATVBAHA.108.168682 10.1371/journal.pone.0102641 10.1161/ATVBAHA.112.251538 10.1096/fj.201601225RR 10.2337/db08-1228 10.1007/s00125-009-1482-9 10.1038/sj.ijo.0801459 10.1210/jcem.81.8.8768851 10.1161/JAHA.116.004503 10.1016/j.metabol.2017.08.014 10.1016/S0021-9258(18)38001-3 10.1016/S0891-5849(98)00211-1 10.1016/S0009-3084(02)00101-9 10.1021/bi800786q 10.1016/j.freeradbiomed.2011.01.002 10.4239/wjd.v6.i3.456 10.1007/s00216-013-7534-5 10.1074/jbc.M110.137257 10.1111/j.1365-2265.2011.04244.x 10.1021/ac0481001
International Journal of Legal Medicine; Nariai M, Abe H et. al.

Jan 21st, 2022 - Acute metabolic disorders of diabetes mellitus (DM), such as diabetic ketoacidosis, hyperosmolar hyperglycemic state, and hypoglycemia, are life-threatening and difficult to diagnose postmortem owing to lack of macroscopic and microscopic findings...

COVID-19 in two children with new-onset diabetes: case reports.
BMJ Case Reports; Lança A, Rodrigues C et. al.

Jan 20th, 2022 - Delayed diagnosis, low socioeconomic status and infection have been associated with diabetic ketoacidosis (DKA) at type 1 diabetes mellitus presentation. A teenager from a low socioeconomic status family, with longstanding weight loss, polyphagia,...

Economic Disparities Among Pediatric Diabetic Ketoacidosis Readmissions in the U.S.
Diabetes Care; Shaka H

Jan 20th, 2022 - Economic Disparities Among Pediatric Diabetic Ketoacidosis Readmissions in the U.S.|2022|Shaka H,|

see more →

Guidelines  5 results

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 17th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 11th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Management of immune-related adverse events in endocrine organs induced by immune check...
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Dying well with diabetes.
Annals of Palliative Medicine; James J

Jan 30th, 2019 - Death is an inevitable part of living. There are undoubtedly clinical and psychological challenges when any individual is passing from life to death. For a person with a long-term condition such as diabetes, these challenges can be compounded and ...

Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS...
Diabetic Medicine : a Journal of the British Diabetic Ass... Price HC, Ismail K et. al.

Aug 29th, 2018 - The Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS) for Inpatient Care guidelines for the management of diabetes in adults and children with psychiatric disorders in inpatient settings are available in full...

see more →

Drugs  365 results see all →

Clinicaltrials.gov  39 results

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treat...

Jan 11th, 2022 - Empagliflozin (Jardiance), a highly potent and selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2), was approved in Europe in May 2014 for the treatment of type 2 diabetes mellitus (T2DM) to improve glycaemic control in adults. As pa...

Irisin And Diabetic Nephropathy

Dec 3rd, 2021 - It is associated with acute and chronic complications, acute complications include hypoglycemia, diabetic ketoacidosis, hyperglycemic hyperosmolar state, and hyperglycemic diabetic coma. Chronic complications are further divided into microvascular...

Bridging the Gap to Adult Diabetes Care

Nov 8th, 2021 - Adolescents with type 1 diabetes face particular challenges related to having a chronic illness that requires daily intensive self-management and medical follow-up during a period when their social, developmental, educational, and family situation...

The Artificial Pancreas in Very Young Children With T1D

Sep 14th, 2021 - Purpose of clinical trial: To determine whether 24/7 automated hybrid closed loop will improve glucose control as measured by time within the target range compared with sensor augmented pump therapy in very young children with T1D. Study objective...

Carbohydrates Under Target for Type 1 Diabetes Management

Jul 13th, 2021 - Recently, there has been an increased interest in limiting carbohydrates (CHO) intakes for improving long-term health. Low CHO (<30% energy from CHO) and very low CHO high fat (VLCHF; 10% CHO, 75% Lipid) diets are being advocated among people livi...

see more →

News  357 results

Obesity Hypoventilation Syndrome Ups Risk in DKA Hospitalization

Jan 21st, 2022 - The study covered in this summary was published in Preprints With The Lancet and has not yet been peer reviewed. Key Takeaways Patients with diabetes who were hospitalized for diabetic ketoacidosis (DKA) had worse outcomes if they also had obesity...

Artificial Pancreas Improves Glycemic Control in Young Kids With T1D

Jan 19th, 2022 - A hybrid closed-loop system, also known as an artificial pancreas, improved glycemic control for very young kids with type 1 diabetes, the randomized KidsAP study confirmed. Among 74 kids ages 1 to 7 years, percentage of time in the target glucose...

Blastomycosislike Pyoderma: Verrucous Hyperpigmented Plaques on the Pretibial Shins
Lisa Cotter, MD, Kyle Cheng, MD et. al.

Dec 20th, 2021 - To the Editor: Blastomycosislike pyoderma (BLP), also commonly referred to as pyoderma vegetans, is a rare cutaneous bacterial infection that often mimics other fungal, inflammatory, or neoplastic disorders. 1 It is characterized by a collection of.

Outrage Over Dapagliflozin Withdrawal for Type 1 Diabetes in EU

Dec 15th, 2021 - In a shock, yet low-key, announcement, the sodium-glucose transporter 2 (SGLT2) inhibitor dapagliflozin (Forxiga, AstraZeneca) has been withdrawn from the market in all EU countries for the indication of type 1 diabetes. This includes withdrawal i...

SPECIAL REPORT-J&J kept quiet on popular diabetes drug as red flags multiplied

Dec 8th, 2021 - (For more Reuters Special Reports, click on) RARITAN, New Jersey, Dec 8 (Reuters) - Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: People taking the company’s new blockbuster diabetes drug were...

see more →

Patient Education  5 results see all →